YDES YD Bio Limited - Ordinary Shares

NASDAQ · Biotechnology
$4.00
Price · Aug 19, 2026

YDES Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$4.00
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$2 – $25

YDES Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
YDES
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
YDES
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
YDES
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
YDES
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
YDES
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
YDES
Peer Median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Next Report
Sep 23, 2026

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
YDES
MENS

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 12 filers · $626K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 (+4 vs prior Q) 0 (-2 vs prior Q) 4 (-1 vs prior Q) 1 (0 vs prior Q) +119K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Garrett Wealth Advisory Group, LLC $190,418 84,630 30.42% Shares
GEODE CAPITAL MANAGEMENT, LLC $141,106 62,714 22.54% Shares
Cypress Capital Management LLC (WY) $75,803 33,690 12.11% Shares
Cerity Partners LLC $72,914 32,406 11.65% Shares
CITADEL ADVISORS LLC $67,739 30,106 10.82% Shares
JANE STREET GROUP, LLC $39,218 17,430 6.27% Shares
UBS Group AG $27,432 12,192 4.38% Shares
WOLVERINE ASSET MANAGEMENT LLC $10,994 4,886 1.76% Shares
WELLS FARGO & COMPANY/MN $169 75 0.03% Shares
MORGAN STANLEY $108 48 0.02% Shares
FMR LLC $2 1 0.00% Shares
ROYAL BANK OF CANADA $0 117 0.00% Shares

Company insiders 2 insiders · 0 officers · 2 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Kochi Chang Director March 31, 2026 M 2,081 0 0 $0
Shao-Ta Lu Director March 31, 2026 M 2,081 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only